Cited by 166Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Insights on the pathophysiology of Alzheimer's disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system

Open access
Dá Mesquita, Sandro, Ferreira, Ana Catarina, Sousa, João Carlos, Correia-Neves, Margarida, Sousa, Nuno, Marques, Fernanda·2016·Neuroscience & Biobehavioral Reviews

Abstract

Alzheimer's disease (AD) is the most common form of dementia, whose prevalence is growing along with the increased life expectancy. Although the accumulation and deposition of amyloid beta (Aβ) peptides in the brain is viewed as one of the pathological hallmarks of AD and underlies, at least in part, brain cell dysfunction and behavior alterations, the etiology of this neurodegenerative disease is still poorly understood. Noticeably, increased amyloid load is accompanied by marked inflammatory alterations, both at the level of the brain parenchyma and at the barriers of the brain. However, it is debatable whether the neuroinflammation observed in aging and in AD, together with alterations in the peripheral immune system, are responsible for increased amyloidogenesis, decreased clearance of Aβ out of the brain and/or the marked deficits in memory and cognition manifested by AD patients. Herein, we scrutinize some important traits of the pathophysiology of aging and AD, focusing on the interplay between the amyloidogenic pathway, neuroinflammation and the peripheral immune system.

Integrity signals

Registry

Crossref · 10.1016/j.neubiorev.2016.06.014

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • At 15 months, intense pathology is present in the TG mice, including Aβ plaques, tau, myelin damage, axonal degeneration, axonal loss, and an inflammatory reaction with reactive microglia and astrocytes.

    “At 15 months, intense pathology is present in the TG mice, which includes not only Aβ plaques and tau, but also confounding factors, such as, myelin damage, axonal degeneration, axonal loss, and an inflammatory reaction with reactive microglia and astrocytes [29, 30].”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dá Mesquita, S., Ferreira, A. C., Sousa, J. C., Correia-Neves, M., Sousa, N., & Marques, F.
Affiliations
University of Minho (PT)
Corresponding author
Marques, Fernanda
Venue
Neuroscience & Biobehavioral Reviews
Publisher
Elsevier BV
Published
2016-09
Volume
68
Pages
547-562
ISSN
0149-7634 (ISSN-L)
OpenAlex
W2424200948
Cited by
166
References
56
Citations by year
2026: 7 · 2025: 12 · 2024: 15 · 2023: 29 · 2022: 11 · 2021: 15 · 2020: 16 · 2019: 17 · 2018: 18 · 2017: 24 · 2016: 1
FWCI
2.35
Type
journal article
Language
en
Open access
Locations
  • Neuroscience & Biobehavioral Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • RepositóriUM (Universidade do Minho) (submittedVersion, other-oa)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-nc-nd)
Funders
  • FCT and COMPETE
  • Bial Foundation (217/12)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, amyloid-beta, neuroinflammation, peripheral immune system, aging, amyloidogenesis, amyloid clearance, blood-brain barrier, neurodegeneration, memory impairment
MeSH terms
Aging, Alzheimer Disease, Brain, Humans, Immune System, Amyloid beta-Peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review